RION Forms INTENT Biologics to Develop Clinical Exosome-Based Therapies
With the launch of INTENT Biologics, RION targets global impact in inflammation care; Suneet Varma named CEO to lead the charge.
Rare Diseases | 11/09/2025 | By Dineshwori
PLI Scheme Brings Down Rare Disease Treatment Costs from Crores to Lakhs: Pharma Secretary
The Production Linked Incentive (PLI) Scheme for pharmaceuticals has significantly reduced the cost of treating rare diseases in India, bringing expenses down from crores to just a few lakhs, said Amit Agrawal, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
Rare Diseases | 22/08/2025 | By Dineshwori
Lupin Announces Appointment of Claus Jepsen as President-Global Specialty
Claus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.
Rare Diseases | 22/10/2024 | By Aishwarya | 193
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy